WCN26-8802 Pembrolizumab-Associated Acute Kidney Injury: Incidence, Risk Factors, and Outcomes

Read full text Summarise with VIRAT
Authors: Nicole Y T Tan, Gabrielle Moe, Jyoti Baharani
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, significantly improving survival across various malignancies. However, ICIs are associated with immune-related adverse events (irAEs) involving multiple organ systems, including the kidneys.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Acute Kidney Injury Research Renal Diseases and Glomerulopathies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104036–104036
Publication date
25 March 2026
Language
EN